Referenser

TASC II. (Eur J Vasc Endovasc Surg 2007; 33:suppl 1.)

SBU rapport ”Benartärsjukdom – diagnostik och behandling”, 2007.

A new pharmacological treatment for intermittent claudication.
(Beebe HG, Dawson DL, Cutler BS, et al. Arch Intern Med 1999; 159: 2041-2050.)

Cilostazol: A review of its use in intermittent claudication. (Chapman et al. American Journal of Cardiovascular Drugs 2003; 3 (2):117–38.)

Meta Analysis of Results from Eight Randomized, Placebo-Controlled Trials on the Effect of Cilostazol on Patients Intermittent Claudication. (Thompson PD et al. AM J Cardiol 2002; 90: 1314-1319.)

Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study. (Hiatt WR et al. J Vasc Surg 2008;47: 330-336.)